Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neuroscience ; 156(1): 184-92, 2008 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-18678231

RESUMEN

Prostaglandin D2(PGD2) is the most produced prostanoid in the CNS of mammals, and in behavioral experiments it has been implicated in the modulation of spinal nociception. In the present study we addressed the effects of spinal PGD2 on the discharge properties of nociceptive spinal cord neurons with input from the knee joint using extracellular recordings in vivo, both in normal rats and in rats with acute inflammation in the knee joint. Topical application of PGD2 to the spinal cord of normal rats did not influence responses to mechanical stimulation of the knee and ankle joint except at a high dose. Specific agonists at either the prostaglandin D2 receptor 1 (DP1) or the prostaglandin D2 receptor 2 (DP2) receptor had no effect on responses to mechanical stimulation of the normal knee. By contrast, in rats with inflamed knee joints either PGD2 or a DP1 receptor agonist decreased responses to mechanical stimulation of the inflamed knee and the non-inflamed ankle thus reducing established inflammation-evoked spinal hyperexcitability. Vice versa, spinal application of an antagonist at DP1 receptors increased responses to mechanical stimulation of the inflamed knee joint and the non-inflamed ankle joint suggesting that endogenous PGD2 attenuated central sensitization under inflammatory conditions, through activation of DP1 receptors. Spinal application of a DP2 receptor antagonist had no effect. The conclusion that spinal PGD2 attenuates spinal hyperexcitability under inflammatory conditions is further supported by the finding that spinal coapplication of PGD2 with prostaglandin E2 (PGE2) attenuated the PGE2-induced facilitation of responses to mechanical stimulation of the normal joint.


Asunto(s)
Vías Aferentes/metabolismo , Artralgia/metabolismo , Artritis/metabolismo , Nociceptores/metabolismo , Células del Asta Posterior/metabolismo , Prostaglandina D2/metabolismo , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Enfermedad Aguda , Vías Aferentes/fisiopatología , Animales , Artralgia/fisiopatología , Artritis/fisiopatología , Dinoprostona/metabolismo , Dinoprostona/farmacología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Miembro Posterior/inervación , Miembro Posterior/fisiopatología , Estimulación Física , Células del Asta Posterior/efectos de los fármacos , Prostaglandina D2/farmacología , Ratas , Receptores Inmunológicos/agonistas , Receptores Inmunológicos/metabolismo , Receptores de Prostaglandina/agonistas , Receptores de Prostaglandina/metabolismo , Tarso Animal/inervación , Tarso Animal/fisiopatología
2.
Br J Pharmacol ; 104(1): 178-82, 1991 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-1786510

RESUMEN

1. The effects of paracetamol and lysine acetylsalicylate (L-AS) on high-threshold mechanonociceptors have been investigated by recording neural activity from the inflamed ankle joint in anaesthetized rats with mild adjuvant-induced monoarthritis. 2. Paracetamol (50 mg kg-1, i.v.) and L-AS (100 mg kg-1, i.v., equivalent to 50 mg kg-1 aspirin) both caused a maximal reduction of about 40% in mechanically-evoked discharge and of 30% in ongoing (spontaneous) activity by about 15 min after the injection: a second dose of either drug did not have any significant additional effect on discharge. 3. The prostanoid IP receptor agonist, cicaprost (0.1-0.5 micrograms), increased both mechanically-evoked and ongoing discharge to pre-paracetamol levels when injected close-arterially 30-50 min after paracetamol, whereas prostaglandin E2 (PGE2) was relatively ineffective at restoring activity. 4. The results suggest that prostacyclin (PGI2) contributes to the sensitization of high-threshold joint mechanonociceptors in adjuvant-induced monoarthritis, and that paracetamol and L-AS both act to reduce discharge by inhibiting the synthesis of prostacyclin in the joint capsule. 5. Paracetamol has a direct peripheral action affecting joint capsule mechanonociceptors in rat adjuvant-induced arthritis which is very similar to that of the soluble aspirin preparation, L-AS. These findings, together with the existing literature concerning the anti-arthritic effects of paracetamol, are relevant to the treatment of chronic inflammatory disorders such as rheumatoid arthritis.


Asunto(s)
Acetaminofén/farmacología , Artritis Experimental/fisiopatología , Aspirina/farmacología , Mecanorreceptores/efectos de los fármacos , Neuronas/efectos de los fármacos , Nociceptores/efectos de los fármacos , Acetaminofén/sangre , Animales , Antiinflamatorios no Esteroideos/farmacología , Aspirina/análogos & derivados , Epoprostenol/análogos & derivados , Epoprostenol/farmacología , Lisina/análogos & derivados , Lisina/farmacología , Masculino , Conducción Nerviosa/efectos de los fármacos , Dolor/fisiopatología , Ratas , Ratas Endogámicas , Salicilatos/sangre , Salicilatos/farmacología , Umbral Sensorial/efectos de los fármacos , Tarso Animal/inervación , Tarso Animal/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA